Skip to content

Tubeless NOSES Versus Laparoscopic Radical Resection for Rectosigmoid Cancers

A Perspective Study to Compare the Tubeless NOSES and Traditional Laparoscopic Radical Resection in Rectosigmoid Cancers (CORNER)

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04037956
Acronym
CORNER
Enrollment
458
Registered
2019-07-30
Start date
2019-06-01
Completion date
2027-07-31
Last updated
2022-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectosigmoid Cancers, Traditional Laparoscopic Radical Resection, Tubeless NOSES

Keywords

Tubeless NOSES, traditional laparoscopic radical resection, Rectosigmoid Cancers

Brief summary

This study is designed to evaluate the short-term and long-term results after Tubeless NOSES for the resection of Rectosigmoid Cancers compared with traditional laparoscopic radical resection.

Detailed description

This is a randomized, single-center, open-label, non- inferiority study designed to evaluate the safety, efficacy and potential benefits of Tubeless NOSES compared with traditional laparoscopic radical resection in approximately 458 subjects with Rectosigmoid Cancers.

Interventions

PROCEDURETubeless NOSES

The whole procedures undergo by total laparoscopic surgery with no specimen extraction incision in the abdominal wall. The specimen then will be removed through natural orifice such (anal).

PROCEDUREtraditional laparoscopic radical resection

The traditional laparoscopic operation undergo and then a small incision(5-8cm) is made in the middle of the lower abdominal wall to remove the specimen.

Sponsors

Sixth Affiliated Hospital, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Histologically or cytologically confirmed Rectosigmoid Cancers 2. Clinical stage at T 1-3 N0-2 M0 3. Tumors on peritoneal reflection,Tumor size is no more than 3 cm 4. Eastern Cooperative Oncology Group (ECOG) scale is 0-2 5. American Society of Anesthesiologists (ASA) score is Ⅰ-Ⅲ 6. BMI ≤ 30 kg/m2 7. Subjects must be willing and able to comply with scheduled visits, treatment schedule,and laboratory testing.

Exclusion criteria

1. Heart, lung, liver or renal or any organ function that are intolerance for surgery 2. History of treated colorectal malignant disease 3. Subjects with medical condition, such as intestinal obstruction, intestinal perforation, bleeding, requires emergency surgery 4. Subjects with previous malignancies 5. History of inflammatory bowl disease(IBD) or familial adenomatous polyposis (FAP) 6. Treatment with any other clinical trial within 28 days prior to randomization 7. History of severe mentally disease 8. pregnant or lactating women 9. The researchers believe that the patients are unsuitable to participate in the researchers with other cases.

Design outcomes

Primary

MeasureTime frame
3-year disease free survival rate36 months after surgery

Secondary

MeasureTime frameDescription
Incidence of postoperative complications1 month after surgeryAll postoperative complications in the perioperative period will be classified by the Clavien-Dindo classification.
the functional outcome of defecation60 months after surgeryAnal incontinence was evaluated using the Wexner Continence Grading Scale , the score being calculated after the patients' completion of a daily defecatory questionnaire. Range is from 0 (normal continence) to 20 (maximum incontinence with maximum disturbance of lifestyle).
the operation timein the perioperative periodThe descriptive unit would be minute (min).
the blood loss during the operationin the perioperative periodThe descriptive unit would be millilitre (ml)
5-year overall survival rate60 months after surgery
Pain scorein the perioperative periodA Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.For example, the amount of pain that a patient feels ranges across a continuum from none to an extreme amount of pain ( from 0 to 10).
number of cases converted to laparotomyin the perioperative periodThe procedure for cases who underwent traditional laparoscopic radical resection for those who cannot be done with traditional laparoscopic radical resection or Tubless NOSES and convert to laparotomy as a result,these should be recorded and compared within two experimental arms.
the mean postoperative hospitalization dayin the perioperative periodThe descriptive unit would be day (d).
Postoperative recovery of intestinal peristalsisin the perioperative periodThe descriptive unit would be hour (h).

Countries

China

Contacts

Primary ContactYanxin Luo, MD,PHD
luoyx25@mail.sysu.edu.cn86-13826190263
Backup ContactJinxin Lin, MD,PHD
linjx69@mail2.sysu.edu.cn86-18998815200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026